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TECHNICAL NOTES Open Access
An isolated perfused pig heart model for the
development, validation and translation of novel
cardiovascular magnetic resonance techniques
Andreas Schuster1†, Inga Grünwald2†, Amedeo Chiribiri1, Richard Southworth1, Masaki Ishida1, Gunnar Hay2,
Nicole Neumann2, Geraint Morton1, Divaka Perera1,3, Tobias Schaeffter1, Eike Nagel1*
Abstract
Background: Novel cardiovascular magnetic resonance (CMR) techniques and imaging biomarkers are often
validated in small animal models or empirically in patients. Direct translation of small animal CMR protocols to
humans is rarely possible, while validation in humans is often difficult, slow and occasionally not possible due to
ethical considerations. The aim of this study is to overcome these limitations by introducing an MR-compatible,
free beating, blood-perfused, isolated pig heart model for the development of novel CMR methodology.
Methods: 6 hearts were perfused outside of the MR environment to establish preparation stability. Coronary
perfusion pressure (CPP), coronary blood flow (CBF), left ventricular pressure (LVP), arterial blood gas and electrolyte
composition were monitored over 4 hours. Further hearts were perfused within 3T (n = 3) and 1.5T (n = 3) clinical
MR scanners, and characterised using functional (CINE), perfusion and late gadolinium enhancement (LGE) imaging.
Perfusion imaging was performed globally and selectively for the right (RCA) and left coronary artery (LCA). In one
heart the RCA perfusion territory was determined and compared to infarct size after coronary occlusion.
Results: All physiological parameters measured remained stable and within normal ranges. The model proved
amenable to CMR at both field strengths using typical clinical acquisitions. There was good agreement between
the RCA perfusion territory measured by selective first pass perfusion and LGE after coronary occlusion (37% versus
36% of the LV respectively).
Conclusions: This flexible model allows imaging of cardiac function in a controllable, beating, human-sized heart
using clinical MR systems. It should aid further development, validation and clinical translation of novel CMR
methodologies, and imaging sequences.
Background
Coronary artery disease (CAD) with subsequent myocar-
dial infarction and heart failure constitutes a leading
cause of death in the western world [1]. Myocardial
ischaemia is the major pathophysiological mechanism
underlying these cardiovascular diseases.
Cardiovascular magnetic resonance (CMR) is being
used increasingly in the diagnosis and assessment of
CAD as it has the unique capability of assessing myocar-
dial function, viability and perfusion in one session [2].
It also compares favourably with other non-invasive
methods [3-6]. This high-resolution technique has
evolved rapidly over the past few years with the develop-
ment of new hardware, contrast agents, acquisition
sequences and new post-processing tools. These recent
and ongoing advances bring the promise of improved
diagnostic accuracy and understanding of the pathophy-
siology and, most importantly, improved management of
the disease [7]. However these new methods have to be
developed and validated before finally being translated
to patients.
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Novel CMR techniques and imaging biomarkers are
often validated in small animal models or empirically in
patients. Direct translation of small animal CMR ima-
ging protocols to humans is rarely possible. On the
other hand, validation of novel imaging techniques in
humans, for example quantitative perfusion, novel
sequences, optimized contrast agent injection schemes
or responses to alterations of blood flow requires large
patient populations and is occasionally not possible for
ethical reasons.
In order to observe cardiovascular physiology and
pathophysiology in a controlled fashion, complex experi-
mental models are necessary to mimic the human situa-
tion as closely as possible. The porcine heart closely
resembles the human heart from the point of view of
size, physiology and anatomy and consequently pigs are
frequently used for in vivo cardiovascular research [8].
Oscar Langendorff introduced a model of retrograde
perfusion of mammalian hearts via the Aorta with Krebs
Henseleit solution in 1895 [9]. This preparation was
refined by using whole blood as a perfusate and by
either perfusing the coronary arteries directly or filling
of the atria and chambers in a working heart mode in
pigs [10-12].
Explanted haemoperfused pig heart models have been
developed to represent in situ physiological cardiac
function ex vivo [10]. They have been used for various
purposes including studies of cardiac physiology and
comparison of different techniques of donor heart pre-
servation [11], but have not yet been exploited for clini-
cal CMR, most likely due to practical difficulties such as
perfusion rig design within the magnetic resonance
(MR) environment.
The purpose of this work is to design, build and test
the feasibility of a novel MR compatible explanted, beat-
ing pig heart model that allows control of regional
blood flow, oxygenation and nutrient delivery. Such a
model would allow validation of CMR derived para-
meters against gold standards and easy translation of
novel CMR methods to patients, using equipment and
imaging sequences that mimic routine clinical practice.
Methods
The work was carried out in two phases.
In phase 1 (n = 6 hearts) we validated the model
against several in-vivo physiological parameters, and
characterised its stability outside of the MR environ-
ment. In phase 2 (n = 6 hearts) after re-developing the
model to be MR compatible we determined its feasibility
at 3 Tesla (n = 3 hearts) and 1.5 Tesla (n = 3 hearts)
clinical MR scanners.
Experiments were conducted after approval by the
relevant authorities. All experiments were performed in
compliance with the World Medical Association
Declaration of Helsinki regarding ethical conduct of
research involving animals.
Phase 1
Heart removal and preparation
Hearts were harvested from Large White Cross Land-
race pigs weighing between 40 and 60 kg (average
weight of 51 ± 6 kg) as previously described [12]. In
brief, pigs were premedicated with 6 mg/kg azaperone
and 0.05 mg/kg atropine, and then anaesthetised with
10 mg/kg ketamine and ventilated with N2O at 4.5 l/
min and O2 at 4 l/min. General anaesthesia was main-
tained with 0.8-1.1 vol.% isoflurane and 1-3 μg/kg/h fen-
tanyl. The animals were heparinised with 5,000 IU of
heparin, the thorax was opened and 1.8 l of autologous
blood was collected via the superior vena cava into 1l
plastic bottles containing 10,000 I.U. heparin. The peri-
cardium was opened and the heart was removed after
transection of the great heart vessels.
The heart was immediately immersed in iced 0.9% sal-
ine solution and the coronary arteries were perfused
with cold (4°C) Custudiol solution (HTK solution,
Dr. Franz Köhler Chemie GmbH, Alsbach-Hähnlein,
Germany).
Hearts were transported to the laboratory and pre-
pared for perfusion as follows. The pulmonary artery
was shortened to 3-3.5 cm and the aorta to approxi-
mately 4 cm. Both vessels were attached to an appropri-
ate cannula. The remaining orifices were sewn closed.
Warm ischaemic time from excision to beginning of
cardioplegic infusion was less than one minute. Cold
ischaemic time (from excision to reperfusion) ranged
between 83 and 146 minutes (106 ± 22, MW ± SD).
During the preparation, hearts were maintained in a
cold cardioplegic solution to avoid rewarming.
Perfusion system
We performed the experiments in a system for direct
coronary perfusion, in which the left and right coronary
artery can be perfused independently of each other
(Figure 1). The heart was connected to the system with
an aortic cannula inserted into the Aorta. The aortic
cannula contained catheters to selectively perfuse right
and left coronary arteries, to allow precise control of
regional myocardial perfusion.
The perfusion system consisted of two separate cir-
cuits - the haemoperfusate circuit to supply the heart
with nutrients and oxygen and the dialysate circuit for
the exchange of metabolites and clearance of contrast
agent (Figure 1). To avoid temperature loss the heart
was suspended in whole blood in a purpose designed
warm water-jacketed heart chamber. Blood temperature
and oxygenation were controlled by an oxygenator with
an integrated heat exchanger (Dideco D 100, Mirandola,
Modena, Italy). The perfusate consisted of autologous
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whole blood (1.8 litre), diluted with Krebs-Henseleit
solution (1 litre, 9.6 g dry mass, Sigma, St. Louis, MO,
USA, Krebs-Henseleit buffer K-3753). To adjust the pH,
CO2 was added if required.
Connection to the perfusion system and reperfusion
Following cannulation, hearts were connected to the
perfusion apparatus and perfusion of the coronary
arteries was started at an initial pressure of 50 mmHg.
Approximately 2 minutes after the start of perfusion the
pressure was increased to 70 mmHg. In the event of
ventricular fibrillation electrical defibrillation was per-
formed. After a stabilisation period of 10 to 15 minutes
coronary blood flow (CBF) was adjusted to reach a CPP
between 60 and 80 mmHg. All hearts were perfused for
4 hours.
Measurements on the isolated hearts
Left ventricular pressure (LVP), right ventricular pres-
sure (RVP), coronary perfusion pressure (CPP) and cor-
onary blood flow (CBF) were assessed every 30 minutes.
Arterial blood gas analysis and oximetry were performed
every 15 minutes and included partial oxygen (pO2) and
partial carbon dioxide (pCO2) pressure in addition to
pH, haemoglobin, sodium, potassium, calcium, chloride,
glucose and lactate.
Phase 2
Within phase 2 hearts were commercially purchased
from Harlan Laboratories UK. Hearts were harvested
from Large White Cross Landrace pigs weighing
between 40 and 60 kg (average weight of 49 ± 5 kg).
Due to local requirements the protocol differed as
follows: Pigs were sedated with 10 mg/kg i.m. ketamine
and 0.3 mg/kg i.m. xylazine. General intravenous anaes-
thesia was achieved with 1.5 mg/kg i.v. alphaxolone.
Coronary arteries were perfused with 20 ml sterile con-
centrate for cardioplegia infusion (Martindale Pharma-
ceuticals, Romford, Essex, UK) diluted immediately
before use in 1 litre of Ringer’s Solution.
Modified MR-Compatible perfusion system
We re-developed the model to be run in the MR envir-
onment. The setup consisted of MR safe and MR com-
patible parts. All equipment in the scanner was made of
MR safe materials [13], i.e. not influencing the MR-
homogeneity of the main magnetic field. Electrical and
magnetic parts (control-unit, power-supply, pumps,
pacer etc.) were made MR compatible by placing them
approximately 6 metres away from the magnet outside
the 5 Gauss line (Figure 2). The pump engines were
connected to the custom-made pump heads using poly-
carbon drive shafts. The cylindrical chamber for the per-
fused heart was made of perspex, which has a magnetic
susceptibility close to water and therefore these materi-
als are not affecting the B0-homogeneity and thus image
quality as described by Schenck [14]. ECG-triggering
was performed by means of a small animal MR ECG
system (SA Instruments, Stony Brook, NY, USA). Pacing
Figure 1 Schematic view of the perfusion system. Starting from the perfusate reservoir (38°C) the perfusate is first passed through roller pump 2
into a dialysis module and then through a blood oxygenator with integrated heat exchanger. The oxygenated blood is then pumped into the heart
via roller pump 1. Before entering the heart an air trap removes air bubbles from the perfusate. The dialysate (38°C) is pumped through the dialysis
module with a centrifugal pump (pump 3, flow of 5 l min -1) to exchange metabolites (contrast agent clearance) between the venous perfusate and
the dialysate. The dialysate is re-circulated in a reservoir. T: sensor for dialysate temperature; O2 and CO2: valves for oxygen and carbon dioxide input.
The perfusate reservoir and the venous and arterial blood circuits are fully water-jacketed. Temperature is controlled by an external heater.
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wires were custom made from copper and connected to
a clinical pacing system (Biotronik EDP 20, Berlin, Ger-
many). Temperature was monitored by an MR compati-
ble thermocouple. This set-up allowed us to run the
same system within the MR scanner as the one we had
developed for the non MR environment.
Measurement of interference with Image quality of the
perfusion system
Designing the perfusion system to be MR-compatible
ensures that the equipment does not adversely affect the
function of the MR scanner, i.e. no significant image
artefacts or noise. Since all equipment inside the MR
scanner was made of MR safe material the main source
of potential image degradation would be due to radiofre-
quency (rf)-interference of equipment (e.g. control-unit,
power-supply, pumps, pacer etc.) with the MR scanner.
In order to test the potential rf-interference, MR images
without rf-excitation were acquired with a perfused
heart inside the MR scanner. The resulting noise images
allowed for detecting any rf-signal within the bandwidth
used by the MR image acquisition. In particular, images
with a bandwidth of 185 kHz were acquired at three
different centre frequencies ensuring an rf sweep across
a 550 kHz range around the MR resonance frequency.
This range covers the range of frequencies that can be
acquired in CMR. To compare this to the background
level of noise, the same experiment was also acquired
with all equipment switched off as well as without
equipment in the room.
Cardiovascular magnetic resonance
CMR was carried out on a clinical 3 Tesla MR scanner
(Achieva, Philips, Best, The Netherlands) and on a clini-
cal 1.5 Tesla MR scanner (Intera CV, Philips, Best, The
Netherlands). For signal reception, a clinical 32-channel
coil array was positioned around the heart chamber,
which was then placed in the magnet.
CMR data were acquired in short axis and long axis
(2-chamber, 3-chamber and 4-chamber view) of the LV.
We used a balanced steady state free precession (SSFP)
sequence with a repetition time of 3 ms, echo time of
1.5 ms, flip angle 40°, spatial resolution at 2 × 1.6 ×
8 mm3 for CINE imaging. For perfusion MR imaging we
used a saturation recovery gradient echo pulse sequence
accelerated with k-t SENSE with a repetition time of 2.4
ms, echo time of 0.8 ms, flip angle 20°, spatial resolution
at 1.3 × 1.3 × 8 mm3. A volume of 5 ml of Gadobutro-
lum at a concentration of 7 mmol/l (Gadovist, Schering,
Berlin, Germany) followed by a saline flush of 10 ml
was administered either into the common arterial inflow
line supplying both coronary arteries or selectively into
the RCA or LCA through the aortic cannulae for selec-
tive first pass perfusion imaging. Late gadolinium
enhancement (LGE) CMR was performed in identical
slice orientations using conventional methods with a
repetition time of 4.9 ms, echo time of 2.4 ms, flip angle
15°, spatial resolution at 1.7 × 1.7 × 8 mm3.
Three hearts at 3 T (n = 3) and three hearts at 1.5 T
(n = 3) were perfused for 240 minutes with constant
blood flow and oxygenation. In one heart at 3 T (n = 1)
blood flow was kept constant for 60 minutes with subse-
quent occlusion of the RCA for 180 minutes. All hearts
underwent CINE imaging, selective first-pass perfusion
and LGE imaging.
Results
Phase 1
Haemoperfusion of six hearts was performed in a direct
coronary perfusion mode. Hearts were defibrillated 2-5
times with 30 Joule to reach stable electrical activity with
synchronous ventricular contraction. Successful recovery
occurred in 6 out of 6 hearts. Heart rate ranged between
60 and 110 beats per minute. Arterial blood gas analysis
revealed stable metabolism (Table 1) at a controlled level
of coronary perfusion within a near normal physiological
range. Normal values of CBF and CPP were maintained
throughout the experiments (Figure 3).
Figure 2 MR compatible model. Column A, B and C show the technical setup of the MR compatible perfusion system in detail. A and B All
electrical parts (control-unit, power-supply, pumps etc.) are placed approximately 6 metres away from the magnet. The pump engines were
then connected to the custom made pump heads using polycarbon drive shafts. C Detail of the trolley containing dialysis unit and oxygenator.
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Phase 2
Interference with image quality of the perfusion system
The acquired noise images showed no significant rf-
interference of the equipment inside the MR room with
the MR scanner. In particular, no additional high rf-
signals were observed over the complete frequency
range of 550 kHz, which would result in strong image
artefacts. However, a small increase (15%) of the noise
level was found when the electrical equipment inside
the MR-room was switched on.
Cardiovascular magnetic resonance
Hearts were defibrillated with 30 Joule 3 times on aver-
age. We performed CINE imaging, first pass perfusion
imaging and LGE imaging. The image quality was com-
parable to clinical scanning (Figure 4, 5 and 6).
Signal intensity curves during first pass perfusion ima-
ging were obtained in a view perpendicular to the heart
chamber. The image plane contained a perpendicular
cut through the arterial inflow tubing (arterial input
function) and a short axis view of the myocardium
(myocardial response curve) (Figure 4).
By selective injection of gadolinium contrast agent
into RCA and LCA the spatial extent of the respective
territories was determined (Figure 5).
In one heart at 3 T blood flow was kept constant for
the first 60 minutes. After standard assessment of ven-
tricular function the perfusion territory of the RCA was
mapped by first pass perfusion (Figure 6B). The RCA
was subsequently occluded for 180 minutes. We found
good agreement between the left ventricular myocar-
dium in the RCA territory identified by first pass perfu-
sion prior to RCA occlusion and the left ventricular
territory identified by LGE (Figure 6C) imaged 180 min-
utes after RCA occlusion. The RCA territory measured
using the short axis RCA first pass perfusion stack was
96 g representing 37% of the total (258 g) left ventricu-
lar myocardial mass. The RCA territory measured using
LGE imaging which represents infarction was 95 g or
36% of the total LV mass (Figure 6).
Discussion
The data presented here demonstrate the potential of an
isolated, blood-perfused pig heart preparation as an
experimental tool to validate newly developed CMR tech-
niques and assess numerous physiological parameters.
Our study demonstrates that 1.) stable near physiolo-
gical conditions are obtained during normal perfusion
and oxygenation of the heart, 2.) the model can be safely
Table 1 Arterial Blood Gas Analysis and Oxymetry (average and standard deviation for n = 6 pigs)
Perfusion Time
[min]
0 15 30 60 90 120 150 180 210 240
pH 7,66 ±
0,15
7,55 ± 0,1 7,51 ±
0,14
7,45 ±
0,04
7,42 ±
0,04
7,4 ± 0,03 7,39 ±
0,02
7,38 ±
0,04
7,41 ±
0,03
7,43 ±
0,04
pO2 [mmHg] 299 ± 49 265 ± 146 273 ± 86 252 ± 28 215 ± 50 230 ± 40 271 ± 40 282 ± 50 273 ± 55 280 ± 38
pCO2 [mmHg] 20 ± 7 26 ± 6 27 ± 5 32 ± 4 34 ± 4 35 ± 3 36 ± 4 36 ± 5 33 ± 5 32 ± 5
tHb [g/dl] 5,7 ± 0,8 4,9 ± 0,4 5,3 ± 0,6 4,5 ± 0,6 4,5 ± 0,4 4,9 ± 0,8 4,7 ± 0,4 5,2 ± 0,6 4,7 ± 0,6 4,5 ± 0,4
Calcium [mmol/L] 0,45 ±
0,02
1,16 ±
0,12
1,23 ± 0,1 1,28 ±
0,11
1,28 ±
0,11
1,27 ±
0,11
1,28 ±
0,11
1,28 ±
0,12
1,27 ±
0,11
1,26 ±
0,11
Potassium [mmol/L] 5 ± 0,1 5,1 ± 0,1 5,1 ± 0,1 5,1 ± 0,2 5,1 ± 0,2 5,1 ± 0,2 5,2 ± 0,2 5,3 ± 0,2 5,3 ± 0,2 5,3 ± 0,2
Sodium [mmol/L] 132 ± 6 131 ± 5 131 ± 4 132 ± 4 132 ± 4 132 ± 4 132 ± 4 132 ± 4 133 ± 4 133 ± 4
Chloride [mmol/L] 111 ± 3 110 ± 4 111 ± 5 110 ± 5 110 ± 4 110 ± 4 111 ± 4 110 ± 4 111 ± 4 111 ± 5
Glucose [mmol/L] 8,7 ± 0,3 8,5 ± 0,1 8,4 ± 0,1 8 ± 0,2 7,8 ± 0,2 7,5 ± 0,1 7,1 ± 0,2 6,7 ± 0,2 6,6 ± 0,2 6,3 ± 0,2
Lactate [mmol/L] 0,5 ± 0,2 0,7 ± 0,2 0,9 ± 0,2 1,1 ± 0,2 1,3 ± 0,2 1,5 ± 0,2 1,7 ± 0,2 2 ± 0,3 2,3 ± 0,3 2,6 ± 0,4
Figure 3 Average coronary blood flow and perfusion pressure
during phase 1. Coronary Perfusion Pressure (CPP, [mmHg]) and
Coronary Blood Flow (CBF [ml/min/100 g]) during 240 minutes of
direct coronary perfusion.
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run in an MR scanner, 3.) interventions such as down-
regulation of flow or occlusion of a coronary artery can
be easily performed and 4.) imaging of the beating, iso-
lated, blood-perfused pig heart system is feasible in a
clinical system using imaging sequences identical to
those used for patient examinations.
Pigs have been widely used in cardiovascular research.
Cardiac energetics have been studied in stunned, hiber-
nating and hypertrophied myocardium [15-18]. Graded
ischaemia [19], ischaemic preconditioning [20] and the
coronary microcirculation [21] have all been studied in
different porcine models. In vivo imaging in pig models
has previously been used to study coronary blood-flow
using coloured microspheres [22], microvascular function
using computer tomography (CT) [23], and to validate
novel perfusion tracers for positron emission tomography
(PET) [24]. Other applications include validation of
MR-guided real time coronary catheterization or percuta-
neous transluminal balloon angioplasty in aortic coarcta-
tion [25,26].
Advances in MR such as novel contrast agents [27],
T2 weighted sequences for the detection of oedematous
tissue [28] or quantitative assessment of myocardial per-
fusion were initially validated in pigs [29]. Schmitt et al.
demonstrated correlation between experimentally
reduced coronary perfusion measured with quantitative
CMR and fluorescently labelled microspheres [30].
Recently Christian and co-workers elegantly used this
Figure 4 Determination of signal intensity curves during first pass perfusion in the isolated pig heart. The figure shows a short axis cut
through one isolated pig heart imaged at 1.5 Tesla. The image plane contains a perpendicular cut through the arterial inflow tubing. The arterial
input function including prebolus can be obtained from the blood pool during first pass of gadolinium. The myocardial response curve can be
obtained shortly afterwards during wash-in of contrast media into the myocardium. The images have been segmented to improve visibility.
Figure 5 Selective perfusion imaging of the right coronary artery (RCA) and left coronary artery (LCA) perfusion territories in the
isolated pig heart. Figure 5 show two short axis slices during first pass perfusion of gadolinium imaged at 3 Tesla after selective injection into
the right and left coronary artery, respectively. A Anatomic reference plane (basal slice). B k-t SENSE selective RCA first pass perfusion. C k-t
SENSE selective LCA first pass perfusion. The images have been segmented to improve visibility.
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animal model to compare CMR quantitative myocardial
perfusion imaging at 1.5 and 3 Tesla [31].
The isolated pig heart model is a useful tool. Whilst it
is not as physiological as intact animals it offers much
greater control and reproducibility. It can be run in a
coronary perfusion mode or in a working heart mode
and can either be perfused with crystalloid solution or
whole blood.
Previous work has been performed in hearts from the
abattoir [10,32] or in surgically explanted hearts [33].
The pathophysiology of cardiac arrhythmias and electri-
cal conduction of endocardial pacing were studied in
coronary perfused pig hearts [33,34]. This perfusion
mode was also used to study right and left ventricular
performance in neonatal hearts [35] and to compare
different techniques of donor heart preservation [11].
Furthermore preclinical high-field Rubidium-87 MR
spectroscopy imaging at 7 Tesla has been used to study
ischaemia and infarction in coronary blood-perfused pig
hearts [36].
Modersohn and co-workers studied transmyocardial
laser revascularisation in a 2-chamber (left atrium and
left ventricle) working heart [37] whilst Chinchoy et al.
studied cardiac physiology in a crystalloid solution per-
fused 4-chamber working heart [38]. Intracardiac digital
imaging of valvular motion [39] and fluorimetric evalua-
tion of function [12] were also investigated under work-
ing conditions.
Finally isolated non-beating porcine hearts have been
previously investigated by MR myocardial perfusion
imaging to compare kinetics of different contrast agents
and to investigate the microcirculation of transplant
hearts [40,41].
The present study to the best of our knowledge is the
first to demonstrate the feasibility of perfusing a beating
heart system in a clinical MR scanner. Our current
model has several important advantages over other
experimental designs, but also some limitations, which
need to be considered. The main advantage is the mod-
el’s precision allowing accurate control of regional and
global perfusion and oxygenation, as well as controlled
nutrient delivery. Whole heart or regional ischaemia can
easily be induced and adjusting perfusion can control
the severity of ischaemia. Pig hearts are well suited for
studies of myocardial blood flow as they have virtually
no anastamoses between adjacent coronary perfusion
beds (Figure 6) [8]. This anatomical homogeneity means
that studies are much more reliable and reproducible.
The model is also free from external influences such
as neuro-humoral activation- the effects of which are
difficult to quantify. In addition in contrast to in vivo
preparations the isolated heart preparation allows
experiments to be continued after fatal events (e.g.
infarction induced cardiac arrest or arrhythmias), which
can frequently terminate an in vivo experiment.
Despite making the system MR compatible we were
able to keep the short tubing and the small volume of
the circuit. This is important as it allows the use of a
mixture of autologous blood and crystalloid solution
with near normal haematocrit and haemoglobin without
the need for donor or support animals. Perfusion with
blood leads to more stable function and less oedema
compared to crystalloid solution perfusion [8].
The main disadvantages of this model are the less
physiological environment compared to in vivo experi-
ments, the ischaemic period after heart removal and the
high associated costs.
Limitations
For studies of myocardial perfusion rapid recirculation
of contrast is prevented in the current model. This is an
oversimplification of in vivo conditions but allows for
Figure 6 Perfusion territory and Size of Infarction. The perfusion territory of the RCA was mapped in the 3 Tesla scanner by first pass
perfusion with direct injection of the contrast agent into the RCA (central image). The perfusion territory was 96 g (36% of left ventricular
myocardial mass). Then the RCA was occluded for 180 minutes. Late gadolinium enhancement (LGE, image on the right) resulted in 95 g
myocardial infarction (36% of LV mass). The close agreement of LGE and selective RCA perfusion highlights the almost complete absence of
collaterals in pigs. A Anatomic reference plane (midmyocardial slice). B k-t SENSE selective RCA first pass perfusion. C LGE image after 180
minutes of RCA occlusion. The images have been segmented to improve visibility.
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repeated perfusion scans. In addition contrast arrival
time was longer compared with in vivo as a conse-
quence of distribution and dilution in the inflow-tubing.
Whether this influences quantitative perfusion analysis
with CMR needs to be investigated.
As this was a feasibility study we did not perform
metabolic assessment of the 6 hearts we perfused in the
magnets. Therefore stable physiological function was
assumed on the basis of the previously performed vali-
dation experiments. Future trials aiming to answer spe-
cific questions need to include metabolic measurements
relevant to the nature of the hypothesis and to assure
stable, robust and reproducible conditions for the speci-
fic scientific question.
We performed a proof of concept study to demon-
strate the feasibility of the model in the MR environ-
ment and thus we did not perform systematic statistical
analysis.
Conclusions
The current work demonstrates for the first time the
feasibility of operating and imaging an isolated beating
porcine heart preparation in a clinical MR scanner. The
technical design of this isolated pig heart model allows
ex vivo simulation and imaging of cardiac function. This
novel system provides excellent control of physiological
parameters and allows validation of novel techniques
against gold standards and easy translation of the meth-
ods to patients using identical equipment and imaging
sequences.
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